Intravenous Vitamin C as an Add-on Therapy for the Treatment of Sepsis in an Intensive Care Unit: A Prospective Cohort Study.
Sergio Antonio Gonzalez-VazquezEli Efrain Gomez-RamirezGonzalez-Lopez LauraJorge Ivan Gamez-NavaJuan Angel Peraza-ZaldivarAline Priscilla Santiago-GarciaMelissa Ramirez-VillafañaFabiola Gonzalez-PonceJose Jorge Gomez-CamarenaAna Miriam Saldaña-CruzNorma Alejandra Rodriguez-JimenezJ Ahuixotl Gutierrez-AcevesAdriana Jimenez-LopezSylvia Elena Totsuka-SuttoErnesto German Cardona MuñozPonce-Guarneros Juan ManuelPublished in: Medicina (Kaunas, Lithuania) (2024)
Background and Objectives : According to the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3), sepsis is defined as "life-threatening organ dysfunction caused by a dysregulated host response to infection". The increased presence of free radicals causes an increase in oxidative stress. Vitamin C is an essential water-soluble vitamin with antioxidant activity and immunoregulatory effects that plays a potential role in the treatment of bacterial infections. Our aim was to evaluate the effectiveness of adding vitamin C to the conventional treatment of sepsis to decrease its mortality rate. Materials and Methods: In a prospective cohort study, we included patients with a diagnosis of sepsis and a SOFA score ≥ 9 who were evaluated in an Intensive Care Unit at a secondary-care hospital. According to the intensive care specialist, they were treated using two different strategies: Group 1-patients with sepsis treated with conventional treatment without vitamin C; Group 2-patients with sepsis with the addition of vitamin C to conventional treatment. Results: We included 34 patients with sepsis. The incidence of mortality was 38%, and 47% of patients used vitamin C as an adjuvant to the basic treatment of sepsis. In the basal analyses, patients treated with use of vitamin C compared to patients treated without vitamin C required less use of glucocorticoids (75% vs. 100%, p = 0.039). At follow-up, patients treated without vitamin C had higher mortality than patients treated with vitamin C as an adjuvant for the treatment of sepsis (55.6% vs. 18.8%, p = 0.03). We observed that the use of vitamin C was a protective factor for mortality in patients with sepsis (RR: 0.54, 95% CI: 0.31-0.96, p = 0.03). Conclusions: The use of vitamin C as an adjuvant to treatment decreases the risk of mortality by 46% in patients with sepsis and SOFA ≥ 9 compared to patients treated without vitamin C as an adjuvant to sepsis.
Keyphrases
- intensive care unit
- septic shock
- acute kidney injury
- oxidative stress
- early stage
- emergency department
- randomized controlled trial
- type diabetes
- low dose
- cardiovascular events
- palliative care
- dna damage
- chronic kidney disease
- coronary artery disease
- end stage renal disease
- chronic pain
- ejection fraction
- signaling pathway
- prognostic factors
- diabetic rats
- acute respiratory distress syndrome
- clinical practice
- patient reported outcomes
- drug induced